MIRA INFORM REPORT

 

 

Report No. :

349929

Report Date :

24.11.2015

 

IDENTIFICATION DETAILS

 

Name :

KILITCH DRUGS (INDIA) LIMITED

 

 

Registered Office :

C-301/2, M.I.D.C. TTC Industrial Area, Pawane Village, Thane - 400 705, Maharashtra

Tel. No.:

91-22-27670322

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

12.05.1992

 

 

Com. Reg. No.:

11-066718

 

 

Capital Investment / Paid-up Capital :

Rs. 132.318 Million

 

 

CIN No.:

[Company Identification No.]

L24239MH1992PLC066718

 

 

IEC No.:

0394053435

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACK2917R

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Subject is engaged into manufacturing of marketing a host of formulations in all dosage forms i.e. Solid, Liquid and Parenteral forms.

 

 

No. of Employees :

Information declined by the management 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 3400000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Kilitch Drugs (India) Limited was incorporated in the year 1992. It is a pharmaceutical company, engaged into manufacturing of marketing a host of formulations in all dosage forms i.e. Solid, Liquid and Parenteral forms.

 

The rating on company reflects its strong financial risk profile, capital structure backed by its zero debt balance sheet profile.

 

The rating further takes consideration on company experienced promoters and well established track record of its operations.

 

However, the company has incurred losses from its operations and recorded sharp decline into its cash and bank balance during the year under review.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

In view of aforesaid, the company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

INFORMATION DECLINED BY

 

Name :

Mr. Chitoor Seshadri Krishnan

Designation :

Chief Financial Officer

Contact No.:

91-22-27670322

Date :

18.11.2015

 

 

LOCATIONS

 

Registered Office :

C-301/2, M.I.D.C. TTC Industrial Area, Pawane Village, Thane - 400 705, Maharashtra, India

Tel. No.:

91-22-27670322, 27680913, 65144185

Fax No.:

91-22-27680912

E-Mail :

finance@kilitch.com

info@killitch.com

Website :

www.killitch.com

 

 

Administrative Office:

Ujagar Industrial Estate, Unit No. 37, W.T. Patil Marg, Deonar, Mumbai - 400 088, Maharashtra, India

Tel. No.:

91- 22-67033322/61214100

Fax No.:

91- 22-67031658

E-Mail :

info@killitch.com

 

 

DIRECTORS

 

AS ON 31.03.2015

 

Name :

Mr. Mukund P Mehta

Designation :

Managing Director

 

 

Name :

Mr. Paresh P Mehta

Designation:

Joint Managing Director

 

 

Name :

Mr. Bhavin M. Mehta

Designation :

Executive Director

 

 

Name :

Mira Mehta

Designation :

Whole time Director

 

 

Name :

Mr. Deepu Pannankattil

Designation :

Whole time Director

 

 

Name :

Mr. Mukesh Shah

Designation :

Independent Director

 

 

Name :

Mr. Pankaj Kamdar

Designation :

Independent Director

 

 

Name :

Mr. Shailesh Chheda

Designation :

Independent Director

 

 

Name :

Mr. Hemang Jagadish Engineer

Designation:

Independent Director

 

 

Name :

Mr. Ramesh Modi

Designation :

Independent Director

 

 

KEY EXECUTIVES

 

Name :

Mr. Chitoor Seshadri Krishnan

Designation :

Chief Financial Officer

 

 

Name :

Mr. Nirmal Kumar

Designation :

Company Secretary and Compliance Officer

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2015

 

Category of Shareholder

No. of Shares

Percentage of Holding

(A) Shareholding of Promoter and Promoter Group

 

 

(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

1801531

13.62

http://www.bseindia.com/include/images/clear.gifBodies Corporate

6629342

50.10

http://www.bseindia.com/include/images/clear.gifSub Total

8430873

63.72

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

8430873

63.72

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

100

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

100

0.00

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

228628

1.73

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

Individual shareholders holding nominal share capital up to Rs.0.100 million

3215381

24.30

Individual shareholders holding nominal share capital in excess of Rs.0.100 million

996161

7.53

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

360685

2.73

http://www.bseindia.com/include/images/clear.gifClearing Members

70286

0.53

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

168593

1.27

http://www.bseindia.com/include/images/clear.gifHindu Undivided Families

121806

0.92

http://www.bseindia.com/include/images/clear.gifSub Total

4800855

36.28

Total Public shareholding (B)

4800955

36.28

Total (A)+(B)

13231828

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

13231828

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged into manufacturing of marketing a host of formulations in all dosage forms i.e. Solid, Liquid and Parenteral forms.

 

 

Products :

  • Solid
  • Liquid
  • Parenteral forms

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

Information declined by the management 

 

 

Bankers :

  • The Shamrao Vithal Co-Operative Bank Limited
  • Axis Bank Limited

 

Banker Name

State Bank of India

Branch Address

Not Divulged

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

Auditors :

 

Name :

A.M. Ghelani and Company

Chartered Accountants

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiary of the Companies:

  • Monarchy Healthserve Private Limited. (W.e.f. F .Y. 2014-15)

 

 

Enterprises significantly influenced by Key Managerial Personnel:

  • NBZ Pharma Limited
  • NBZ Healthcare LLP.
  • J.D. Enterprises
  • Kilitch Pharma (Company) Limited
  • EyeKare Kilitch Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2015

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20000000

Equity Shares

Rs. 10/- each

Rs.200.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

13231828

Equity Shares

Rs. 10/- each

Rs.132.318 Million

 

 

 

 

 

Reconciliation of the number of shares outstanding at the beginning and at the end of the reporting period

 

Name of Shareholder

Number of Shares

Rs. In Million

Equity Shares outstanding at the beginning of the year

13231828

132.318

Additions during the year

--

--

Equity Shares bought back during the year

--

--

Equity Shares outstanding at the end of the year

13231828

132.318

 

 

Shares in the company held by each shareholder holding more than 5 percent shares

 

Name of Shareholder

Number of Shares

 

% of holding

Paresh P. Mehta

956785

7.23

Kilitch Company Pharma Limited

6629342

50.10

 

The company has only one class of Equity Shares having a face value of Rs.10 per share. Each holder of Equity Share is entitled to one vote per share.


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

132.318

132.318

132.318

(b) Reserves & Surplus

1067.436

1069.964

1058.200

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1199.754

1202.282

1190.518

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

1.508

2.543

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.000

1.508

2.543

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

23.552

46.803

134.776

(c) Other current liabilities

39.116

35.327

37.183

(d) Short-term provisions

5.464

4.770

3.630

Total Current Liabilities (4)

68.132

86.900

175.589

 

 

 

 

TOTAL

1267.886

1290.690

1368.650

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

93.425

92.733

87.463

(ii) Intangible Assets

0.411

0.593

1.277

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

471.556

11.970

7.158

(c) Deferred tax assets (net)

5.082

0.000

0.000

(d)  Long-term Loan and Advances

230.999

226.862

11.183

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

801.473

332.158

107.081

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

246.687

391.633

1082.771

(b) Inventories

23.812

25.990

15.392

(c) Trade receivables

126.230

86.340

123.979

(d) Cash and cash equivalents

49.802

438.526

29.407

(e) Short-term loans and advances

19.255

15.394

10.020

(f) Other current assets

0.627

0.649

0.000

Total Current Assets

466.413

958.532

1261.569

 

 

 

 

TOTAL

1267.886

1290.690

1368.650

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Income

190.273

148.980

331.808

 

 

Other Income

26.902

62.912

92.153

 

 

TOTAL                                              (A)

217.175

211.892

423.961

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

64.859

73.225

265.983

 

 

Variation in inventories of finished goods & work-in-progress

5.302

(14.596)

2.613

 

 

Employee Benefits Expenses

31.280

28.576

30.345

 

 

Operating and Other expenses

105.640

99.661

70.305

 

 

Extraordinary Items

 0.000

0.000 

9.546

 

 

TOTAL                                              (B)

207.081

186.866

378.792

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

10.094

25.026

45.169

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

0.000

0.000

0.122

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

10.094

25.026

45.047

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

18.539

14.397

12.290

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                  (G)     

(8.445)

10.629

32.757

 

 

 

 

 

Less

TAX                                                                  (H)

(6.590)

(1.135)

(0.071)

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

(1.855)

11.764

32.828

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

620.705

608.941

576.113

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

618.850

620.705

608.941

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Sale

95.131

133.203

171.686

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(0.14)

0.89

2.48

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

Net cash flow from / (used in) operating activities

(76.317)

(310.839)

14.973

 

 

QUARTERLY RESULTS

 

 (Rs. In Million)

Particulars

 

 

30.06.2015

(Unaudited)

30.09.2015

(Unaudited)

 

 

1st Quarter

2nd Quarter

Net sales

 

39.940

43.110

Total Expenditure

 

67.050

47.560

PBIDT (Excluding Other Income)

 

(27.110)

(4.450)

Other income

 

5.760

1.780

Operating Profit

 

(21.350)

(2.670)

Interest

 

NA

NA

Exceptional Items

 

NA

NA

PBDT

 

(21.350)

(2.670)

Depreciation

 

3.910

3.910

Profit Before Tax

 

(25.260)

(6.580)

Tax

 

(0.350)

(1.570)

Provisions and contingencies

 

NA

NA

Profit after tax

 

(24.910)

(5.010)

Extraordinary Items

 

NA

NA

Prior Period Expenses

 

NA

NA

Other Adjustments

 

NA

NA

Net Profit

 

(24.910)

(5.010)

 


 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

PAT / Sales

(%)

(0.97)

7.90

9.89

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

5.31

16.80

13.61

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets)

(%)

(1.07)

0.83

2.41

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.01)

0.01

0.03

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

6.85

11.03

7.18

 

 

STOCK PRICES

 

Face Value

Rs.10.00/-

Market Value

Rs.37.60/-

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

Rs. In Million

Rs. In Million

Rs. In Million

Share Capital

132.318

132.318

132.318

Reserves & Surplus

1058.200

1069.964

1067.436

Net worth

1190.518

1202.282

1199.754

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

Rs. In Million

Rs. In Million

Rs. In Million

Sales

331.808

148.980

190.273

 

 

-55.101

27.717

 

 


 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

Rs. In Million

Rs. In Million

Rs. In Million

Sales

331.808

148.980

190.273

Profit

32.828

11.764

(1.855)

 

9.89%

7.90%

(0.97%)

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

No

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

REVIEW OF OPERATIONS

 

During the year, the Company has posted total Income of Rs.217.176 Million as against Rs.211.892 Million for the corresponding previous year. Further, Net Loss after tax for the year was Rs.(1.855) Million as against a Net Profit of Rs.11.764 Million for the corresponding previous year.

 

FUTURE OUTLOOK:

 

As they look ahead, they have set clear goals and aspirations for their next set of milestones. In the medium term, building on proven results, they are leveraging the power of their carefully developed product portfolio, relationships built over a long period and a diversified customer mix. Further, they have an optimized cost structure, robust balance sheet and a highly seasoned professional management. With the ongoing projects of 2 new manufacturing units at Ethiopia and Burkina Faso and incorporation of latest technology and capacity expansion at their Thane factory, they expect speedy positive growth rates. Their Company is well placed to capitalize on the opportunities arising out of such upcoming markets worldwide.

 

Combined with new marketing and branding concepts and improved product portfolio, they will see increased momentum in the coming years. Innovation and Quality remains at the core of all Kilitch initiatives and hence they shall continue to invest in R&D. Even though the economy remains subdued now, they believe it can grow faster, due to the expansion of its international presence and innovative product portfolio. Their company is well positioned to leverage on opportunities worldwide.

 

Focus on Global Business

 

Their company sets the pace when it comes to providing innovative and customer-centric services to the world’s emerging markets having footprints across the globe. Their strength is defined by their major presence in most of the West African countries along with few other African countries. They are now one of the major suppliers for many of the Ministry of Health in Francophone countries particularly, Burkina Faso. Their innovative product offerings have made us to enter successfully in new emerging markets like South East Asia, CIS countries and Gulf countries. A strong entrepreneurial spirit of their international alliance remains one of their quickest and surest routes to success in the years ahead.

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10579714

29/04/2015

100,000,000.00

KOTAK MAHINDRA BANK LIMITED

27BKC, C 27, G BLOCK, BANDRA KURLA COMPLEX, BANDR
A (E),, MUMBAI, MAHARASHTRA - 400051, INDIA

C58784133

2

90141825

26/07/1996 *

3,500,000.00

BANK OF BARODA

PRARTHANA BAMAJ BRANCH, BOMBAY, MAHARASHTRA - 4000
04, INDIA

-

 

* Date of charge modification

 

CONTINGENT LIABILITIES (AS ON 31.03.2015):

 

a. Estimated amount of guarantees and Letter of Credit given not provided for in the accounts is Rs.6.308 Million (Previous Year Rs.6.308 Million).

 

b. The disputed statutory dues in respect of Income Tax aggregating to Rs.50.306 Million pertaining to A.Y. 2008-09 have not been deposited as the matter is pending before the CIT (Appeals).

 

STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2015

 

 (Rs. In Million)

Particulars

Quarter Ended

(Unaudited)

 

30.06.2015

1. Income from operations

 

a) Net sales/ Income from operation (net of excise duty)

39.574

b) Other operating income

0.367

Total income from Operations(net)

70.2025

2.Expenditure

 

a) Cost of material consumed

29.835

b) Changes in inventories of finished goods, work-in-progress and stock-in-trade

(1.324)

c) Employees benefit expenses

8.526

d) Depreciation and amortization expenses

3.914

e) Export product registration charges

1.465

f) Other expenditure

28.544

Total expenses

70.960

3. Profit from operations before other income and financial costs

(31.018)

4. Other income

5.762

5. Profit from ordinary activities before finance costs

(25.256)

6. Finance costs

0.000

7. Net profit/(loss) from ordinary activities after finance costs but before exceptional items

(25.256)

8. Exchange Currency Fluctuation Loss/ (Gain)

0.000

9. Profit from ordinary activities before tax Expense:

(25.256)

10.Tax expenses

(0.352)

11.Net Profit / (Loss) from ordinary activities after tax (9-10)

(24.905)

12.Extraordinary Items (net of tax expense)

0.000

13.Net Profit / (Loss) for the period (11 -12)

(24.905)

14.Paid-up equity share capital (Nominal value Rs.10/- per share)

132.318

15. Reserve excluding Revaluation Reserves as per balance sheet of previous accounting year

 

16.i) Earnings per share (before extraordinary items) of Rs.10/- each) (not annualised):

 

(a) Basic and diluted

(1.88)

 

 

A. Particulars of shareholding

 

1. Public Shareholding

 

- Number of shares

4697655

- Percentage of shareholding

35.50

2. Promoters and Promoters group Shareholding-

 

a) Pledged /Encumbered

 

Number of shares

 

Percentage of shares (as a % of total shareholding of the promoter and promoter group)

0.000

Percentage of shares (as a % of total share capital of the company)

0.000

 

 

b) Non  Encumbered

 

Number of shares

8534173

Percentage of shares (as a % of total shareholding of the promoter and promoter group)

100

Percentage of shares (as a % of total share capital of the company)

64.50

 

 

 

B. Investor Complaints

 

Pending at the beginning of the quarter

Nil

Receiving during the quarter

2

Disposed of during the quarter

2

Remaining unreserved at the end of the quarter

Nil

 

NOTES:

 

1.     The above results as reviewed by the audit committee have been taken on record by the Board of Directors at their meeting held on 14th August, 2015.

 

2.     The Company has operated only in one reportable segment i.e. Pharmaceuticals.

 

3.     The figures for the corresponding previous periods have been restated / regrouped, wherever necessary, to make them comparable with the current periods. Figures of the quarter ended 31-03-2015 are the balancing figures between the audited figures in respect of the full financial year F. Y. 2014-15 and published year to date figures upto the third quarter of the said financial year.

 

FIXED ASSETS

 

Tangible Assets

 

 

Intangible Assets:

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs.66.35

UK Pound

1

Rs.100.66

Euro

1

Rs.70.47

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

KAS

 

 

Report Prepared by :

KVT / NKT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILITY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.